Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.91 trillion, total revenue of $4.7 trillion and a weighted average PE ratio of 49.22.
Market Cap
9.91T
Revenue
4.7T
Profits
201.4B
PE Ratio
49.22
Profit Margin
4.29%
Dividend Yield
0.38%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.26T | 3.19% | 5,252,128 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 657.68B | -0.73% | 8,969,487 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 521.11B | 1.41% | 6,898,179 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 368.89B | 2.18% | 12,345,380 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 365.29B | -0.96% | 4,299,787 | 450.06B |
| 6 | NVS | Novartis AG | 306.70B | -0.19% | 3,152,893 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 290.07B | 7.02% | 5,465,705 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 258.25B | -1.72% | 2,091,838 | 47.35B |
| 9 | AMGN | Amgen Inc. | 251.94B | 1.15% | 3,290,626 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 211.70B | 3.06% | 11,427,257 | 30.99B |
| 11 | ABT | Abbott Laboratories | 183.77B | 1.56% | 8,440,807 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 175.43B | 2.20% | 15,277,511 | 50.34B |
| 13 | PFE | Pfizer Inc. | 173.95B | 1.90% | 45,485,398 | 63.70B |
| 14 | DHR | Danaher Corporation | 163.38B | -2.00% | 3,755,005 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 149.75B | -3.73% | 3,481,628 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 141.65B | 3.50% | 3,030,027 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 127.71B | 1.78% | 12,668,093 | 50.03B |
| 18 | MDT | Medtronic plc | 118.18B | -0.59% | 8,682,968 | 37.54B |
| 19 | MCK | McKesson Corporation | 115.96B | 1.40% | 763,209 | 410.98B |
| 20 | CVS | CVS Health Corporation | 115.43B | -0.09% | 8,187,755 | 412.65B |
| 21 | SYK | Stryker Corporation | 111.11B | -6.38% | 6,438,156 | 26.30B |
| 22 | SNY | Sanofi | 106.67B | 2.81% | 15,101,805 | 57.89B |
| 23 | GSK | GSK plc | 99.63B | 1.71% | 4,767,316 | 44.53B |
| 24 | HCA | HCA Healthcare, Inc. | 98.85B | -1.02% | 1,120,496 | 78.70B |
| 25 | REGN | Regeneron Pharmaceuticals, Inc. | 93.11B | 13.33% | 2,870,752 | 16.90B |
| 26 | ELV | Elevance Health, Inc. | 90.76B | -0.46% | 1,286,164 | 201.83B |
| 27 | MRNA | Moderna, Inc. | 88.52B | -0.47% | 9,009,239 | 2.23B |
| 28 | CI | The Cigna Group | 78.80B | -0.06% | 1,862,172 | 282.38B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 67.38B | 4.50% | 4,624,379 | 29.86B |
| 30 | COR | Cencora, Inc. | 63.13B | 0.09% | 1,347,722 | 332.77B |
| 31 | BSX | Boston Scientific Corporation | 60.84B | -1.66% | 22,467,158 | 21.07B |
| 32 | NTRA | Natera, Inc. | 59.72B | -4.98% | 2,432,184 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 58.00B | -0.24% | 1,945,005 | 254.25B |
| 34 | ARGX | argenx SE | 56.37B | -0.55% | 462,446 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 53.90B | -0.23% | 2,920,044 | 22.48B |
| 36 | EW | Edwards Lifesciences Corporation | 53.03B | -2.57% | 6,044,702 | 6.51B |
| 37 | VEEV | Veeva Systems Inc. | 50.67B | 0.84% | 1,375,031 | 3.46B |
| 38 | HUM | Humana Inc. | 49.77B | -0.52% | 887,969 | 145.68B |
| 39 | A | Agilent Technologies, Inc. | 49.30B | -3.47% | 2,756,524 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 49.05B | 1.50% | 7,357,871 | 17.32B |
| 41 | WAT | Waters Corporation | 45.46B | -3.61% | 1,342,325 | 4.64B |
| 42 | IQV | IQVIA Holdings Inc. | 44.06B | -2.81% | 1,150,294 | 17.31B |
| 43 | IDXX | IDEXX Laboratories, Inc. | 43.42B | -4.30% | 1,174,194 | 4.55B |
| 44 | MDLN | Medline Inc. | 42.23B | 0.37% | 14,573,304 | 29.94B |
| 45 | ONC | BeOne Medicines AG | 42.11B | -0.33% | 292,821 | 6.13B |
| 46 | RVMD | Revolution Medicines, Inc. | 41.00B | 0.55% | 1,100,530 | - |
| 47 | RPRX | Royalty Pharma plc | 38.63B | 1.90% | 4,662,171 | 2.54B |
| 48 | HLN | Haleon plc | 37.69B | 1.05% | 32,525,872 | 14.80B |
| 49 | BIIB | Biogen Inc. | 37.49B | 1.59% | 1,303,306 | 10.30B |
| 50 | ILMN | Illumina, Inc. | 35.68B | -18.64% | 5,390,386 | 4.54B |
| 51 | GMAB | Genmab A/S | 34.92B | 1.01% | 8,649,172 | 4.13B |
| 52 | ALC | Alcon Inc. | 34.68B | 0.45% | 1,606,445 | 10.86B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 34.62B | 0.20% | 3,967,520 | 21.64B |
| 54 | CNC | Centene Corporation | 33.89B | -0.25% | 4,807,944 | 180.41B |
| 55 | MTD | Mettler-Toledo International Inc. | 33.56B | -2.55% | 189,457 | 4.13B |
| 56 | ZTS | Zoetis Inc. | 32.94B | 1.85% | 4,118,154 | 9.53B |
| 57 | RMD | ResMed Inc. | 32.34B | -9.05% | 3,470,545 | 5.73B |
| 58 | DXCM | DexCom, Inc. | 30.69B | 2.95% | 8,637,527 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 29.34B | -1.84% | 773,389 | 14.59B |
| 60 | WST | West Pharmaceutical Services, Inc. | 28.74B | -0.97% | 1,062,353 | 3.40B |
| 61 | DGX | Quest Diagnostics Incorporated | 27.71B | -0.43% | 919,590 | 11.84B |
| 62 | ROIV | Roivant Sciences Ltd. | 26.66B | -1.63% | 4,574,510 | 7.53M |
| 63 | PHG | Koninklijke Philips N.V. | 26.45B | -0.74% | 1,273,378 | 20.18B |
| 64 | UTHR | United Therapeutics Corporation | 25.68B | 0.87% | 518,241 | 3.15B |
| 65 | INSM | Insmed Incorporated | 24.70B | 0.89% | 5,184,538 | 1.52B |
| 66 | INCY | Incyte Corporation | 24.54B | 3.07% | 2,840,381 | 6.01B |
| 67 | GH | Guardant Health, Inc. | 23.99B | -3.51% | 1,502,199 | 1.18B |
| 68 | BNTX | BioNTech SE | 22.15B | -1.08% | 631,915 | 3.03B |
| 69 | STE | STERIS plc | 22.14B | -2.16% | 992,333 | 6.04B |
| 70 | ALNY | Alnylam Pharmaceuticals, Inc. | 22.10B | -5.17% | 7,056,828 | 5.01B |
| 71 | VTRS | Viatris Inc. | 21.86B | -0.86% | 8,792,669 | 14.74B |
| 72 | THC | Tenet Healthcare Corporation | 21.75B | 0.99% | 1,209,489 | 22.15B |
| 73 | MEDP | Medpace Holdings, Inc. | 18.24B | -3.77% | 219,453 | 2.84B |
| 74 | ZBH | Zimmer Biomet Holdings, Inc. | 18.03B | -3.03% | 3,605,960 | 8.51B |
| 75 | RVTY | Revvity, Inc. | 17.52B | -5.30% | 3,179,985 | 2.91B |
| 76 | CRL | Charles River Laboratories International, Inc. | 17.16B | -4.44% | 1,503,508 | 4.00B |
| 77 | EXEL | Exelixis, Inc. | 16.93B | 4.82% | 5,072,003 | 2.50B |
| 78 | ASND | Ascendis Pharma A/S | 16.50B | -0.68% | 386,705 | 1.20B |
| 79 | ICLR | ICON Public Limited Company | 15.83B | -1.91% | 2,580,651 | 8.23B |
| 80 | HALO | Halozyme Therapeutics, Inc. | 14.86B | -0.21% | 1,402,422 | 1.66B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 14.85B | -0.19% | 1,322,280 | 3.37B |
| 82 | BBIO | BridgeBio Pharma, Inc. | 14.60B | 5.97% | 5,771,101 | 945.54M |
| 83 | GKOS | Glaukos Corporation | 14.06B | -2.01% | 2,073,931 | 690.33M |
| 84 | JAZZ | Jazz Pharmaceuticals plc | 14.02B | 3.92% | 1,215,116 | 4.60B |
| 85 | BTSG | BrightSpring Health Services, Inc. | 13.93B | 11.08% | 5,936,214 | 15.25B |
| 86 | SOLV | Solventum Corporation | 13.84B | -2.67% | 1,067,231 | 8.31B |
| 87 | EHC | Encompass Health Corporation | 13.41B | 3.35% | 1,797,654 | 6.34B |
| 88 | TEM | Tempus AI, Inc. | 13.03B | -7.22% | 10,457,285 | 1.43B |
| 89 | SMMT | Summit Therapeutics Inc. | 12.82B | -1.05% | 3,508,018 | - |
| 90 | PEN | Penumbra, Inc. | 12.57B | -0.94% | 497,748 | 1.56B |
| 91 | SNN | Smith & Nephew plc | 12.42B | -2.33% | 1,730,144 | 6.30B |
| 92 | FMS | Fresenius Medical Care AG | 11.96B | -2.85% | 967,974 | 22.19B |
| 93 | BAX | Baxter International Inc. | 11.90B | -2.13% | 11,817,506 | 11.61B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.85B | 0.43% | 1,826,385 | 3.44B |
| 95 | DVA | DaVita Inc. | 11.80B | -3.01% | 1,760,643 | 14.17B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.52B | -0.77% | 3,453,607 | 5.02B |
| 97 | TECH | Bio-Techne Corporation | 11.39B | -0.07% | 2,565,855 | 1.22B |
| 98 | BMRN | BioMarin Pharmaceutical Inc. | 11.33B | 1.77% | 2,273,743 | 3.41B |
| 99 | COO | The Cooper Companies, Inc. | 11.32B | -1.31% | 7,892,175 | 4.24B |
| 100 | RGEN | Repligen Corporation | 11.31B | -6.20% | 4,472,065 | 805.61M |
| 101 | AVTR | Avantor, Inc. | 10.88B | -3.78% | 9,733,866 | 6.64B |
| 102 | KYMR | Kymera Therapeutics, Inc. | 10.81B | 3.29% | 1,591,508 | 102.24M |
| 103 | MOH | Molina Healthcare, Inc. | 10.67B | 2.93% | 1,752,977 | 42.08B |
| 104 | ALGN | Align Technology, Inc. | 10.65B | -2.49% | 1,119,667 | 4.16B |
| 105 | ENSG | The Ensign Group, Inc. | 10.50B | -2.58% | 411,633 | 5.67B |
| 106 | GMED | Globus Medical, Inc. | 10.48B | -5.86% | 1,676,978 | 3.14B |
| 107 | QGEN | Qiagen N.V. | 10.39B | -0.24% | 4,168,095 | 2.10B |
| 108 | PODD | Insulet Corporation | 10.38B | -1.85% | 1,090,209 | 3.05B |
| 109 | UHS | Universal Health Services, Inc. | 10.38B | -0.32% | 582,096 | 18.35B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 9.95B | -3.18% | 183,089 | 2.59B |
| 111 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.94B | -0.31% | 251,658 | 1.28B |
| 112 | KRYS | Krystal Biotech, Inc. | 9.84B | 2.38% | 330,314 | 440.48M |
| 113 | PCVX | Vaxcyte, Inc. | 9.76B | -0.93% | 1,714,583 | - |
| 114 | CAI | Caris Life Sciences, Inc. | 9.70B | -5.01% | 3,672,889 | 989.61M |
| 115 | TWST | Twist Bioscience Corporation | 9.58B | -11.92% | 3,399,915 | 431.80M |
| 116 | HSIC | Henry Schein, Inc. | 9.46B | -1.80% | 1,195,428 | 13.60B |
| 117 | PTGX | Protagonist Therapeutics, Inc. | 9.37B | 0.35% | 322,566 | 281.99M |
| 118 | OSCR | Oscar Health, Inc. | 9.36B | -1.36% | 3,639,144 | 15.32B |
| 119 | HNGE | Hinge Health, Inc. | 9.22B | -2.21% | 2,891,944 | 720.06M |
| 120 | TXG | 10x Genomics, Inc. | 9.13B | -14.03% | 5,218,777 | 616.91M |
| 121 | SYRE | Spyre Therapeutics, Inc. | 9.02B | -2.43% | 661,127 | - |
| 122 | IBRX | ImmunityBio, Inc. | 8.79B | -5.15% | 8,960,344 | 165.79M |
| 123 | CORT | Corcept Therapeutics Incorporated | 8.77B | -5.62% | 1,429,164 | 830.81M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.76B | -0.51% | 1,257,213 | 67.67M |
| 125 | ATR | AptarGroup, Inc. | 8.70B | 5.02% | 1,007,402 | 3.99B |
| 126 | BRKR | Bruker Corporation | 8.70B | -7.95% | 1,921,335 | 3.50B |
| 127 | TGTX | TG Therapeutics, Inc. | 8.68B | 5.34% | 2,856,055 | 799.54M |
| 128 | HQY | HealthEquity, Inc. | 8.48B | 1.10% | 717,220 | 1.36B |
| 129 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.46B | -0.98% | 1,124,657 | 669.50M |
| 130 | PRAX | Praxis Precision Medicines, Inc. | 7.98B | -0.93% | 306,555 | 7.46M |
| 131 | ABVX | ABIVAX Société Anonyme | 7.69B | -2.77% | 843,413 | 5.33M |
| 132 | ALKS | Alkermes plc | 7.61B | -0.07% | 1,113,062 | 1.67B |
| 133 | PACS | PACS Group, Inc. | 7.57B | -3.76% | 591,202 | 5.55B |
| 134 | AXSM | Axsome Therapeutics, Inc. | 7.57B | 0.68% | 2,172,345 | 776.57M |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 7.49B | 0.75% | 2,765,563 | 3.12B |
| 136 | GRFS | Grifols, S.A. | 7.30B | 0.75% | 803,384 | 8.48B |
| 137 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.25B | -5.45% | 1,320,330 | 945.96M |
| 138 | IONS | Ionis Pharmaceuticals, Inc. | 7.23B | -1.96% | 1,522,192 | 874.09M |
| 139 | BLCO | Bausch + Lomb Corporation | 7.15B | -1.96% | 1,431,565 | 5.42B |
| 140 | CHE | Chemed Corporation | 6.93B | -1.33% | 180,471 | 2.66B |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.56B | 0.14% | 476,257 | 1.56B |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.46B | -6.71% | 10,859,205 | 2.58B |
| 143 | LGND | Ligand Pharmaceuticals Incorporated | 6.46B | 1.71% | 344,311 | 253.83M |
| 144 | ORKA | Oruka Therapeutics, Inc. | 6.41B | 0.23% | 634,040 | - |
| 145 | GRAL | GRAIL, Inc. | 6.41B | -9.75% | 1,073,440 | 165.26M |
| 146 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.37B | -0.54% | 431,656 | 239.92M |
| 147 | BLTE | Belite Bio, Inc | 6.23B | 2.97% | 234,882 | - |
| 148 | KOD | Kodiak Sciences Inc. | 6.22B | -1.22% | 568,099 | - |
| 149 | IMVT | Immunovant, Inc. | 6.03B | -1.59% | 1,165,434 | - |
| 150 | TFX | Teleflex Incorporated | 5.92B | -1.15% | 891,275 | 2.25B |
| 151 | DOCS | Doximity, Inc. | 5.84B | -2.59% | 2,202,324 | 655.57M |
| 152 | MANE | Veradermics, Incorporated | 5.84B | -2.89% | 465,043 | - |
| 153 | RDNT | RadNet, Inc. | 5.78B | -0.22% | 571,698 | 2.27B |
| 154 | CGON | CG Oncology, Inc. | 5.73B | 1.91% | 870,332 | 6.23M |
| 155 | MIRM | Mirum Pharmaceuticals, Inc. | 5.52B | -1.61% | 673,432 | 618.07M |
| 156 | HAE | Haemonetics Corporation | 5.44B | -0.12% | 453,354 | 1.35B |
| 157 | COGT | Cogent Biosciences, Inc. | 5.38B | -2.94% | 2,495,132 | - |
| 158 | WAY | Waystar Holding Corp. | 5.37B | -0.74% | 1,263,893 | 1.21B |
| 159 | BLLN | BillionToOne, Inc. | 5.35B | -1.32% | 468,308 | 397.41M |
| 160 | SRRK | Scholar Rock Holding Corporation | 5.35B | -0.63% | 769,807 | - |
| 161 | STVN | Stevanato Group S.p.A. | 5.29B | -4.25% | 557,663 | 1.40B |
| 162 | SHC | Sotera Health Company | 5.18B | -2.94% | 3,452,027 | 1.22B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.17B | -7.66% | 1,804,094 | 1.61B |
| 164 | CON | Concentra Group Holdings Parent, Inc. | 5.15B | -2.11% | 989,864 | 2.29B |
| 165 | MMED | MiniMed Group, Inc. | 5.14B | -5.04% | 8,134,038 | 3.22B |
| 166 | HTFL | HeartFlow, Inc. | 5.13B | -2.45% | 2,247,288 | 212.07M |
| 167 | LFST | LifeStance Health Group, Inc. | 5.12B | -1.76% | 2,298,686 | 1.58B |
| 168 | ERAS | Erasca, Inc. | 5.02B | -4.21% | 3,749,485 | - |
| 169 | PTCT | PTC Therapeutics, Inc. | 5.01B | -6.97% | 2,357,646 | 1.16B |
| 170 | CRSP | CRISPR Therapeutics AG | 4.97B | -5.23% | 1,167,709 | 13.39M |
| 171 | DFTX | Definium Therapeutics, Inc. | 4.88B | -4.29% | 1,076,583 | - |
| 172 | OPCH | Option Care Health, Inc. | 4.77B | -0.06% | 4,228,319 | 5.69B |
| 173 | TVTX | Travere Therapeutics, Inc. | 4.75B | -0.36% | 1,140,512 | 591.33M |
| 174 | DNTH | Dianthus Therapeutics, Inc. | 4.61B | -0.39% | 496,894 | 1.90M |
| 175 | CDNA | CareDx, Inc. | 4.59B | 22.22% | 3,554,610 | 497.40M |
| 176 | TLX | Telix Pharmaceuticals Limited | 4.44B | -4.31% | 341,882 | 890.79M |
| 177 | LIVN | LivaNova PLC | 4.35B | -2.81% | 575,598 | 1.47B |
| 178 | ITGR | Integer Holdings Corporation | 4.30B | 0.06% | 571,701 | 1.83B |
| 179 | ADPT | Adaptive Biotechnologies Corporation | 4.25B | -5.43% | 4,256,501 | 308.08M |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 4.22B | -0.03% | 967,632 | - |
| 181 | LEGN | Legend Biotech Corporation | 4.19B | -3.00% | 2,189,662 | 1.27B |
| 182 | INDV | Indivior Pharmaceuticals, Inc. | 4.17B | 0.34% | 4,607,364 | 1.37B |
| 183 | ICUI | ICU Medical, Inc. | 4.10B | -2.89% | 216,558 | 2.16B |
| 184 | IRTC | iRhythm Holdings, Inc. | 4.07B | -3.47% | 533,412 | 825.34M |
| 185 | LQDA | Liquidia Corporation | 4.03B | 0.16% | 2,091,719 | 450.91M |
| 186 | ARQT | Arcutis Biotherapeutics, Inc. | 4.03B | 0.31% | 1,883,905 | 463.98M |
| 187 | RLAY | Relay Therapeutics, Inc. | 4.02B | -5.75% | 3,596,210 | 10.35M |
| 188 | VCYT | Veracyte, Inc. | 4.02B | -4.14% | 1,015,437 | 561.90M |
| 189 | ABCL | AbCellera Biologics Inc. | 3.98B | -6.19% | 3,876,554 | 66.17M |
| 190 | IOVA | Iovance Biotherapeutics, Inc. | 3.84B | -11.30% | 31,202,208 | 324.97M |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.83B | 0.84% | 5,279,371 | 53.81M |
| 192 | NVST | Envista Holdings Corporation | 3.78B | -4.47% | 3,727,983 | 2.86B |
| 193 | PLSE | Pulse Biosciences, Inc. | 3.73B | -5.84% | 466,452 | 1.19M |
| 194 | OGN | Organon & Co. | 3.63B | 0.22% | 1,848,063 | 6.10B |
| 195 | XENE | Xenon Pharmaceuticals Inc. | 3.62B | -0.35% | 1,119,034 | 7.50M |
| 196 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.62B | 0.63% | 989,520 | -665.00K |
| 197 | IRON | Disc Medicine, Inc. | 3.59B | -2.41% | 684,975 | - |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.55B | -0.82% | 1,137,498 | 1.14B |
| 199 | PBLS | Parabilis Medicines, Inc. | 3.50B | -1.32% | 813,967 | 148.00K |
| 200 | VKTX | Viking Therapeutics, Inc. | 3.48B | 1.56% | 5,143,535 | - |
| 201 | CELC | Celcuity Inc. | 3.38B | -0.25% | 700,081 | - |
| 202 | RGC | Regencell Bioscience Holdings Limited | 3.33B | -2.19% | 148,174 | - |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.28B | 0.88% | 595,209 | 606.33M |
| 204 | ELVN | Enliven Therapeutics, Inc. | 3.24B | -1.84% | 1,236,955 | - |
| 205 | NHC | National HealthCare Corporation | 3.23B | -2.84% | 135,881 | 1.56B |
| 206 | DYN | Dyne Therapeutics, Inc. | 3.12B | -2.05% | 1,449,832 | - |
| 207 | ATRC | AtriCure, Inc. | 3.12B | -1.97% | 967,355 | 569.62M |
| 208 | IDYA | IDEAYA Biosciences, Inc. | 3.08B | -2.83% | 838,034 | 234.13M |
| 209 | BHC | Bausch Health Companies Inc. | 3.07B | -7.97% | 8,868,424 | 11.11B |
| 210 | WRBY | Warby Parker Inc. | 3.04B | 0.08% | 2,929,798 | 911.61M |
| 211 | DNLI | Denali Therapeutics Inc. | 3.03B | -1.97% | 1,306,534 | 3.60M |
| 212 | SGRY | Surgery Partners, Inc. | 3.01B | - | 3,514,064 | 3.37B |
| 213 | AXGN | Axogen, Inc. | 2.95B | -0.52% | 1,835,156 | 266.93M |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.93B | -1.18% | 2,311,455 | 701.94M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.87B | -0.75% | 1,338,866 | 2.60B |
| 216 | MESO | Mesoblast Limited | 2.80B | -3.25% | 375,991 | 120.25M |
| 217 | VRDN | Viridian Therapeutics, Inc. | 2.79B | -0.52% | 1,710,586 | 71.13M |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.79B | 1.70% | 2,575,609 | 3.37B |
| 219 | PRVA | Privia Health Group, Inc. | 2.74B | -2.36% | 841,162 | 2.36B |
| 220 | ZLAB | Zai Lab Limited | 2.74B | -1.30% | 637,839 | 449.61M |
| 221 | BEAM | Beam Therapeutics Inc. | 2.72B | -5.58% | 1,500,245 | 156.04M |
| 222 | MBX | MBX Biosciences, Inc. | 2.69B | 2.44% | 667,267 | - |
| 223 | RCUS | Arcus Biosciences, Inc. | 2.62B | -2.26% | 1,935,910 | 117.00M |
| 224 | NEOG | Neogen Corporation | 2.58B | -3.59% | 1,947,001 | 884.00M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | 0.59% | 318,976 | 1.46B |
| 226 | ADMA | ADMA Biologics, Inc. | 2.56B | -2.89% | 2,460,828 | 512.28M |
| 227 | PGEN | Precigen, Inc. | 2.48B | 4.52% | 8,104,565 | 85.72M |
| 228 | BKD | Brookdale Senior Living Inc. | 2.48B | 1.17% | 5,487,398 | 2.93B |
| 229 | SUPN | Supernus Pharmaceuticals, Inc. | 2.44B | 0.19% | 2,818,871 | 865.11M |
| 230 | RXRX | Recursion Pharmaceuticals, Inc. | 2.41B | -4.95% | 24,414,760 | 54.86M |
| 231 | NAMS | NewAmsterdam Pharma Company N.V. | 2.40B | -3.37% | 1,141,136 | 7.12M |
| 232 | CLOV | Clover Health Investments, Corp. | 2.37B | -2.62% | 4,651,445 | 2.48B |
| 233 | CLDX | Celldex Therapeutics, Inc. | 2.36B | 0.70% | 870,776 | 158.00K |
| 234 | PHVS | Pharvaris N.V. | 2.35B | -0.15% | 1,481,528 | - |
| 235 | BHVN | Biohaven Ltd. | 2.33B | -6.49% | 3,164,692 | - |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.32B | 0.64% | 371,489 | 1.10B |
| 237 | HCM | HUTCHMED (China) Limited | 2.31B | -3.24% | 33,492 | 549.12M |
| 238 | ADUS | Addus HomeCare Corporation | 2.30B | 0.97% | 300,312 | 1.48B |
| 239 | TMDX | TransMedics Group, Inc. | 2.29B | -1.68% | 900,110 | 668.47M |
| 240 | MD | Pediatrix Medical Group, Inc. | 2.27B | 2.19% | 1,114,253 | 1.96B |
| 241 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 0.44% | 871,474 | 959.90M |
| 242 | NEO | NeoGenomics, Inc. | 2.25B | -3.07% | 1,464,370 | 787.75M |
| 243 | PGNY | Progyny, Inc. | 2.24B | 2.78% | 807,727 | 1.31B |
| 244 | VERA | Vera Therapeutics, Inc. | 2.23B | 1.47% | 1,083,964 | - |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | -3.25% | 960,844 | 321.74M |
| 246 | XNCR | Xencor, Inc. | 2.22B | 2.09% | 1,289,635 | 104.97M |
| 247 | UFPT | UFP Technologies, Inc. | 2.20B | -3.00% | 85,389 | 631.64M |
| 248 | PRGO | Perrigo Company plc | 2.19B | -0.75% | 3,349,349 | 4.14B |
| 249 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.16B | -0.59% | 3,527,215 | 940.61M |
| 250 | ALMR | Alamar Biosciences, Inc. | 2.12B | -10.11% | 740,070 | 100.42M |
| 251 | PVLA | Palvella Therapeutics, Inc. | 2.11B | -3.58% | 293,056 | - |
| 252 | IMNM | Immunome, Inc. | 2.07B | -0.44% | 1,271,216 | 4.02M |
| 253 | LKFT | Lakefront Biotherapeutics NV | 2.07B | -0.15% | 164,056 | 1.13B |
| 254 | VCEL | Vericel Corporation | 2.06B | -6.18% | 598,736 | 306.30M |
| 255 | WGS | GeneDx Holdings Corp. | 2.06B | -2.76% | 886,155 | 454.43M |
| 256 | FTRE | Fortrea Holdings Inc. | 2.05B | -7.99% | 2,873,554 | 2.67B |
| 257 | SEPN | Septerna, Inc. | 2.05B | -2.72% | 223,450 | 98.88M |
| 258 | SDGR | Schrödinger, Inc. | 2.03B | -9.50% | 1,947,643 | 259.04M |
| 259 | ZYME | Zymeworks Inc. | 2.03B | -0.35% | 2,880,103 | 37.13M |
| 260 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.03B | -7.68% | 1,703,946 | 208.78M |
| 261 | TRLV | Trulieve Cannabis Corp. | 1.98B | -3.02% | 1,413,900 | 1.14B |
| 262 | INSP | Inspire Medical Systems, Inc. | 1.97B | -4.33% | 796,398 | 898.74M |
| 263 | SRPT | Sarepta Therapeutics, Inc. | 1.97B | -3.17% | 1,318,156 | 1.97B |
| 264 | SLS | SELLAS Life Sciences Group, Inc. | 1.95B | -4.72% | 6,261,984 | - |
| 265 | XERS | Xeris Biopharma Holdings, Inc. | 1.95B | -0.37% | 1,550,329 | 335.41M |
| 266 | COAG | Hemab Therapeutics Holdings, Inc. | 1.94B | 2.55% | 765,616 | - |
| 267 | TRVI | Trevi Therapeutics, Inc. | 1.93B | -1.81% | 1,732,019 | - |
| 268 | VIR | Vir Biotechnology, Inc. | 1.91B | -3.83% | 1,269,932 | 303.23M |
| 269 | ABSI | Absci Corporation | 1.91B | -8.02% | 4,565,919 | 1.56M |
| 270 | ADRX | ADARx Pharmaceuticals, Inc. | 1.90B | -4.76% | 542,259 | 6.13M |
| 271 | XRAY | DENTSPLY SIRONA Inc. | 1.90B | -0.83% | 3,497,176 | 3.64B |
| 272 | TRAX | First Tracks Biotherapeutics, Inc. | 1.89B | -0.33% | 434,200 | - |
| 273 | ASTH | Astrana Health, Inc. | 1.87B | -0.25% | 236,663 | 3.84B |
| 274 | ESTA | Establishment Labs Holdings Inc. | 1.86B | -8.70% | 1,033,135 | 264.03M |
| 275 | GENB | Generate Biomedicines, Inc. | 1.86B | -8.31% | 1,170,814 | 26.48M |
| 276 | LMAT | LeMaitre Vascular, Inc. | 1.85B | -5.08% | 427,367 | 262.43M |
| 277 | ZBIO | Zenas BioPharma, Inc. | 1.85B | -1.29% | 358,070 | 1.00M |
| 278 | AMN | AMN Healthcare Services, Inc. | 1.82B | 0.36% | 599,001 | 3.43B |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 1.82B | -17.94% | 3,094,763 | 98.34M |
| 280 | KMTS | Kestra Medical Technologies, Ltd. | 1.77B | -3.01% | 324,917 | 106.73M |
| 281 | BRVE | Braveheart Bio, Inc. | 1.76B | 1.51% | 533,668 | - |
| 282 | NTLA | Intellia Therapeutics, Inc. | 1.75B | -5.74% | 4,087,704 | 59.51M |
| 283 | QURE | uniQure N.V. | 1.72B | -1.86% | 1,895,413 | 18.67M |
| 284 | AZTA | Azenta, Inc. | 1.71B | -5.35% | 902,817 | 613.81M |
| 285 | BFLY | Butterfly Network, Inc. | 1.71B | -14.91% | 7,480,865 | 123.26M |
| 286 | STOK | Stoke Therapeutics, Inc. | 1.70B | -0.23% | 1,856,821 | 28.21M |
| 287 | MAZE | Maze Therapeutics, Inc. | 1.70B | -1.41% | 327,126 | 20.00M |
| 288 | ARDT | Ardent Health, Inc. | 1.70B | -2.20% | 380,273 | 6.41B |
| 289 | PSNL | Personalis, Inc. | 1.69B | -0.66% | 2,364,407 | 69.67M |
| 290 | CERT | Certara, Inc. | 1.68B | -1.61% | 1,946,480 | 421.75M |
| 291 | OMCL | Omnicell, Inc. | 1.67B | -0.62% | 785,544 | 1.24B |
| 292 | NUVB | Nuvation Bio Inc. | 1.67B | -0.21% | 5,063,518 | 169.90M |
| 293 | REPL | Replimune Group, Inc. | 1.67B | 1.27% | 3,853,651 | - |
| 294 | KLRA | Kailera Therapeutics, Inc. | 1.67B | -4.10% | 868,428 | - |
| 295 | NVAX | Novavax, Inc. | 1.66B | -3.72% | 4,061,778 | 413.80M |
| 296 | ALVO | Alvotech | 1.66B | -4.91% | 714,818 | 494.61M |
| 297 | HCSG | Healthcare Services Group, Inc. | 1.65B | -0.65% | 635,004 | 1.88B |
| 298 | SNDA | Sonida Senior Living, Inc. | 1.62B | 0.15% | 466,376 | 481.07M |
| 299 | MLYS | Mineralys Therapeutics, Inc. | 1.61B | -14.41% | 3,979,591 | - |
| 300 | CMPS | COMPASS Pathways plc | 1.60B | -5.09% | 2,180,332 | - |
| 301 | URGN | UroGen Pharma Ltd. | 1.60B | -2.27% | 1,167,548 | 188.73M |
| 302 | NBTX | Nanobiotix S.A. | 1.60B | -7.19% | 235,684 | 13.15M |
| 303 | RARE | Ultragenyx Pharmaceutical Inc. | 1.58B | -4.05% | 2,334,285 | 717.00M |
| 304 | PAHC | Phibro Animal Health Corporation | 1.58B | 0.05% | 182,782 | 1.52B |
| 305 | IMCR | Immunocore Holdings plc | 1.57B | -2.49% | 290,234 | 430.78M |
| 306 | GPCR | Structure Therapeutics Inc. | 1.56B | -0.32% | 696,978 | - |
| 307 | TDOC | Teladoc Health, Inc. | 1.55B | -2.52% | 8,160,355 | 2.47B |
| 308 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | -1.59% | 286,897 | 978.38M |
| 309 | NVCR | NovoCure Limited | 1.54B | 0.31% | 1,974,509 | 725.39M |
| 310 | INVA | Innoviva, Inc. | 1.53B | -0.42% | 623,267 | 440.00M |
| 311 | OCUL | Ocular Therapeutix, Inc. | 1.53B | -4.65% | 2,629,771 | 52.06M |
| 312 | LYCA | Lycia Therapeutics, Inc. | 1.52B | -4.80% | 202,452 | 4.44M |
| 313 | ALHC | Alignment Healthcare, Inc. | 1.52B | -9.80% | 13,820,425 | 4.94B |
| 314 | ETON | Eton Pharmaceuticals, Inc. | 1.49B | -2.78% | 336,108 | 105.60M |
| 315 | RAPP | Rapport Therapeutics, Inc. | 1.48B | 3.47% | 926,561 | 20.00M |
| 316 | PNTG | The Pennant Group, Inc. | 1.46B | -1.93% | 367,829 | 1.10B |
| 317 | PCRX | Pacira BioSciences, Inc. | 1.45B | - | 737,238 | 746.16M |
| 318 | TYRA | Tyra Biosciences, Inc. | 1.45B | -1.91% | 625,770 | - |
| 319 | ANAB | AnaptysBio, Inc. | 1.44B | -0.74% | 293,617 | 106.09M |
| 320 | GHRS | GH Research PLC | 1.43B | -2.98% | 305,401 | - |
| 321 | AGL | agilon health, inc. | 1.43B | -1.21% | 217,460 | 5.92B |
| 322 | KRSA | Korsana Biosciences, Inc. | 1.37B | -0.26% | 104,184 | - |
| 323 | NUTX | Nutex Health Inc. | 1.37B | -4.74% | 120,015 | 846.72M |
| 324 | TSHA | Taysha Gene Therapies, Inc. | 1.35B | -2.13% | 1,501,141 | 5.49M |
| 325 | FRNM | Freenome, Inc. | 1.34B | -2.95% | 651,136 | 35.41M |
| 326 | OMER | Omeros Corporation | 1.33B | -2.69% | 885,579 | 38.42M |
| 327 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | -3.44% | 1,874,210 | 1.04B |
| 328 | NKTR | Nektar Therapeutics | 1.33B | -0.79% | 600,973 | 54.59M |
| 329 | DMRA | Damora Therapeutics, Inc. | 1.33B | -2.36% | 339,519 | - |
| 330 | KARD | Kardigan, Inc. | 1.32B | -1.26% | 452,783 | - |
| 331 | CNMD | CONMED Corporation | 1.32B | -3.13% | 404,078 | 1.37B |
| 332 | USPH | U.S. Physical Therapy, Inc. | 1.28B | -0.85% | 146,429 | 804.27M |
| 333 | LBRX | LB Pharmaceuticals Inc | 1.28B | -1.12% | 429,474 | - |
| 334 | AAPG | Ascentage Pharma Group International | 1.27B | -2.85% | 15,920 | 94.61M |
| 335 | INNV | InnovAge Holding Corp. | 1.25B | -0.54% | 593,062 | 989.71M |
| 336 | OPK | OPKO Health, Inc. | 1.24B | - | 2,149,129 | 587.90M |
| 337 | STAA | STAAR Surgical Company | 1.23B | -2.77% | 535,488 | 339.59M |
| 338 | SVRA | Savara Inc. | 1.22B | -2.63% | 1,412,059 | - |
| 339 | CRON | Cronos Group Inc. | 1.22B | -1.79% | 1,091,082 | 179.09M |
| 340 | SNDX | Syndax Pharmaceuticals, Inc. | 1.22B | -3.53% | 2,539,615 | 252.25M |
| 341 | VOR | Vor Biopharma Inc. | 1.21B | -5.88% | 759,596 | - |
| 342 | DRTS | Alpha Tau Medical Ltd. | 1.21B | -1.28% | 475,324 | - |
| 343 | GDRX | GoodRx Holdings, Inc. | 1.19B | -1.41% | 1,507,527 | 785.23M |
| 344 | SLN | Silence Therapeutics plc | 1.19B | -0.25% | 621,426 | 615.00K |
| 345 | VSTM | Verastem, Inc. | 1.18B | 0.93% | 2,411,811 | 87.53M |
| 346 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.18B | 2.93% | 664,508 | 730.02M |
| 347 | ENOV | Enovis Corporation | 1.15B | -12.71% | 2,524,736 | 2.30B |
| 348 | OMDA | Omada Health, Inc. | 1.15B | -4.68% | 958,628 | 309.76M |
| 349 | AVLN | Avalyn Pharma Inc. | 1.14B | -0.31% | 343,495 | - |
| 350 | CSTL | Castle Biosciences, Inc. | 1.14B | -3.51% | 334,261 | 357.28M |
| 351 | MNKD | MannKind Corporation | 1.13B | - | 2,009,440 | 393.63M |
| 352 | BVS | Bioventus Inc. | 1.12B | -10.39% | 666,689 | 581.85M |
| 353 | AORT | Artivion, Inc. | 1.10B | -3.67% | 627,385 | 471.47M |
| 354 | PRCT | PROCEPT BioRobotics Corporation | 1.10B | -5.42% | 856,458 | 337.34M |
| 355 | LMRI | Lumexa Imaging Holdings, Inc. | 1.10B | -2.73% | 244,492 | 1.04B |
| 356 | ATEC | Alphatec Holdings, Inc. | 1.09B | -38.08% | 27,299,424 | 839.72M |
| 357 | AHG | Akso Health Group | 1.08B | -5.26% | 4,897 | 13.83M |
| 358 | SGP | SpyGlass Pharma, Inc. | 1.08B | -0.83% | 94,147 | - |
| 359 | JANX | Janux Therapeutics, Inc. | 1.07B | -2.02% | 540,038 | 24.00M |
| 360 | HROW | Harrow, Inc. | 1.06B | -5.84% | 335,281 | 275.59M |
| 361 | INBX | Inhibrx Biosciences, Inc. | 1.06B | -2.54% | 438,828 | 1.30M |
| 362 | SPTX | Seaport Therapeutics, Inc. | 1.05B | -7.11% | 549,190 | - |
| 363 | HSTM | HealthStream, Inc. | 1.03B | -0.30% | 151,635 | 321.12M |
| 364 | CTY | City Therapeutics, Inc. | 1.03B | -6.46% | 116,787 | 14.34M |
| 365 | CBLL | CeriBell, Inc. | 1.02B | -4.46% | 582,653 | 101.96M |
| 366 | MLTX | MoonLake Immunotherapeutics | 1.00B | -6.28% | 1,128,536 | - |
| 367 | IART | Integra LifeSciences Holdings Corporation | 991.96M | -0.62% | 1,038,771 | 1.66B |
| 368 | IMTX | Immatics N.V. | 984.17M | -1.50% | 1,715,854 | 47.65M |
| 369 | IRMD | IRADIMED CORPORATION | 980.60M | -10.57% | 218,005 | 89.34M |
| 370 | CGEM | Cullinan Therapeutics, Inc. | 967.25M | -2.72% | 389,415 | - |
| 371 | RIGL | Rigel Pharmaceuticals, Inc. | 958.46M | -0.27% | 174,405 | 276.79M |
| 372 | ORIC | ORIC Pharmaceuticals, Inc. | 957.75M | 2.78% | 2,441,597 | - |
| 373 | SIBN | SI-BONE, Inc. | 951.50M | -5.27% | 1,249,190 | 213.60M |
| 374 | ODTX | Odyssey Therapeutics, Inc. | 936.33M | -1.46% | 166,398 | 99.00K |
| 375 | LTGO | Latigo Biotherapeutics, Inc. | 924.88M | -10.23% | 216,171 | - |
| 376 | GLUE | Monte Rosa Therapeutics, Inc. | 917.97M | -1.01% | 1,349,052 | 28.73M |
| 377 | OBX | Obsidian Therapeutics, Inc. | 913.62M | 1.86% | 563,091 | - |
| 378 | KURA | Kura Oncology, Inc. | 912.74M | -2.84% | 2,252,626 | 77.23M |
| 379 | MGTX | MeiraGTx Holdings plc | 911.45M | -2.27% | 452,178 | 397.50M |
| 380 | BBNX | Beta Bionics, Inc. | 910.65M | -4.72% | 1,073,071 | 127.27M |
| 381 | QDEL | QuidelOrtho Corporation | 908.62M | -3.71% | 1,737,545 | 2.67B |
| 382 | JBIO | Jade Biosciences, Inc. | 894.18M | -1.26% | 682,307 | - |
| 383 | ANRO | Alto Neuroscience, Inc. | 886.87M | -3.71% | 484,413 | - |
| 384 | AKTS | Aktis Oncology, Inc. | 886.02M | -5.46% | 251,543 | 10.06M |
| 385 | ALMS | Alumis Inc. | 871.10M | -2.32% | 2,236,897 | 7.40M |
| 386 | GMRS | GMR Solutions Inc. | 869.71M | -2.01% | 550,210 | 5.88B |
| 387 | PHAR | Pharming Group N.V. | 861.02M | 0.82% | 14,047 | 386.75M |
| 388 | CRVS | Corvus Pharmaceuticals, Inc. | 843.73M | -1.96% | 845,128 | - |
| 389 | PRME | Prime Medicine, Inc. | 839.71M | -9.92% | 6,569,455 | 4.07M |
| 390 | IVA | Inventiva S.A. | 838.96M | -2.14% | 1,730,070 | 2.81M |
| 391 | ABUS | Arbutus Biopharma Corporation | 832.94M | -1.64% | 2,526,176 | 181.72M |
| 392 | PACB | Pacific Biosciences of California, Inc. | 809.71M | -10.17% | 13,737,066 | 159.27M |
| 393 | KIDS | OrthoPediatrics Corp. | 806.03M | -2.06% | 569,925 | 264.14M |
| 394 | CTKB | Cytek Biosciences, Inc. | 796.80M | -2.70% | 1,866,609 | 206.71M |
| 395 | VREX | Varex Imaging Corporation | 776.79M | -0.05% | 460,697 | 865.00M |
| 396 | AHCO | AdaptHealth Corp. | 775.11M | -2.02% | 2,225,392 | 3.36B |
| 397 | COLL | Collegium Pharmaceutical, Inc. | 774.82M | -0.96% | 401,933 | 808.21M |
| 398 | HELP | Helus Pharma Inc. | 774.07M | -1.07% | 1,146,328 | - |
| 399 | PHR | Phreesia, Inc. | 772.16M | -0.72% | 597,727 | 507.79M |
| 400 | SANA | Sana Biotechnology, Inc. | 769.36M | -5.51% | 2,076,881 | - |
| 401 | ANNX | Annexon, Inc. | 767.80M | 1.00% | 2,840,292 | - |
| 402 | BBTX | Bambusa Therapeutics, Inc. | 763.63M | -6.31% | 2,200,122 | - |
| 403 | INMD | InMode Ltd. | 759.90M | -2.15% | 439,914 | 374.63M |
| 404 | ARDX | Ardelyx, Inc. | 755.04M | -2.26% | 3,625,879 | 450.89M |
| 405 | DNA | Ginkgo Bioworks Holdings, Inc. | 754.88M | -12.01% | 2,730,321 | 132.42M |
| 406 | OABI | OmniAb, Inc. | 745.35M | -2.29% | 2,114,015 | 40.21M |
| 407 | AVBP | ArriVent BioPharma, Inc. | 733.21M | -6.77% | 1,194,885 | - |
| 408 | WVE | Wave Life Sciences, Inc. | 708.05M | -1.10% | 3,330,992 | 70.92M |
| 409 | SGMT | Sagimet Biosciences Inc. | 703.41M | -4.89% | 989,149 | - |
| 410 | ACHV | Achieve Life Sciences, Inc. | 702.82M | -5.01% | 1,376,723 | - |
| 411 | ATTO | Attovia Therapeutics, Inc. | 693.44M | -0.52% | 146,674 | 1.80M |
| 412 | SLBT | SL Science Holding Limited | 684.32M | 2.56% | 26,621 | 3.27M |
| 413 | APMD | Apnimed, Inc. | 682.74M | -5.42% | 466,518 | 115.12M |
| 414 | DSGN | Design Therapeutics, Inc. | 668.37M | -3.44% | 249,545 | - |
| 415 | STLN | Starling Oncology, Inc. | 665.51M | -1.80% | 1,422,309 | 587.24M |
| 416 | SLDB | Solid Biosciences Inc. | 664.80M | -2.97% | 873,119 | - |
| 417 | FDMT | 4D Molecular Therapeutics, Inc. | 657.41M | -6.89% | 683,494 | 92.01M |
| 418 | SOPH | SOPHiA GENETICS SA | 649.53M | -4.27% | 379,207 | 86.17M |
| 419 | CADL | Candel Therapeutics, Inc. | 637.40M | -3.70% | 779,926 | - |
| 420 | AURA | Aura Biosciences, Inc. | 636.75M | -2.54% | 533,014 | - |
| 421 | IMMX | Immix Biopharma, Inc. | 636.69M | -3.76% | 1,382,223 | - |
| 422 | IAM | Iambic Therapeutics, Inc. | 636.59M | -5.95% | 476,855 | 18.25M |
| 423 | LXRX | Lexicon Pharmaceuticals, Inc. | 631.84M | -4.05% | 2,444,205 | 41.47M |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 615.29M | -0.50% | 1,880,498 | 8.22M |
| 425 | AVR | Anteris Technologies Global Corp. | 615.18M | -1.71% | 1,396,950 | 2.24M |
| 426 | ANL | Adlai Nortye Group Ltd. | 615.00M | -7.10% | 262,101 | 18.06M |
| 427 | OLMA | Olema Pharmaceuticals, Inc. | 612.48M | -4.50% | 751,361 | - |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 610.47M | -0.77% | 642,043 | 136.07M |
| 429 | MYGN | Myriad Genetics, Inc. | 607.38M | -4.80% | 1,503,680 | 806.60M |
| 430 | BCAX | Bicara Therapeutics Inc. | 604.16M | -6.17% | 4,195,966 | - |
| 431 | NVCT | Nuvectis Pharma, Inc. | 602.11M | -0.48% | 168,908 | - |
| 432 | DBVT | DBV Technologies S.A. | 596.41M | -7.77% | 410,565 | 3.76M |
| 433 | CLYM | Climb Bio, Inc. | 588.72M | -0.77% | 708,754 | - |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 578.34M | -3.31% | 1,470,622 | 389.32M |
| 435 | CBIO | Crescent Biopharma, Inc. | 576.96M | -4.19% | 189,518 | 11.88M |
| 436 | GERN | Geron Corporation | 574.63M | -5.47% | 18,809,283 | 204.56M |
| 437 | FLGT | Fulgent Genetics, Inc. | 567.37M | -4.89% | 201,370 | 323.93M |
| 438 | MDXG | MiMedx Group, Inc. | 566.19M | -2.27% | 2,124,737 | 303.73M |
| 439 | EVO | Evotec SE | 559.29M | -3.16% | 73,253 | 819.47M |
| 440 | STTK | Shattuck Labs, Inc. | 558.02M | -2.80% | 951,481 | 1.00M |
| 441 | ENTX | Entera Bio Ltd. | 556.55M | 2.56% | 292,682 | 42.00K |
| 442 | NGNE | Neurogene Inc. | 551.31M | -4.41% | 249,047 | 925.00K |
| 443 | DRUG | Bright Minds Biosciences Inc. | 544.36M | -3.02% | 95,820 | - |
| 444 | PBYI | Puma Biotechnology, Inc. | 538.91M | -0.95% | 339,537 | 231.24M |
| 445 | TCMD | Tactile Systems Technology, Inc. | 521.91M | -5.22% | 210,712 | 350.31M |
| 446 | VALN | Valneva SE | 519.43M | -4.55% | 7,929 | 163.30M |
| 447 | ARVN | Arvinas, Inc. | 513.94M | -0.51% | 1,125,552 | 316.70M |
| 448 | SGHT | Sight Sciences, Inc. | 513.42M | -2.61% | 267,519 | 83.38M |
| 449 | OCS | Oculis Holding AG | 509.91M | 0.24% | 309,704 | 1.45M |
| 450 | CTMX | CytomX Therapeutics, Inc. | 509.88M | 2.18% | 4,944,660 | 18.30M |
| 451 | ETRA | Electra Therapeutics, Inc. | 508.41M | -6.25% | 150,597 | - |
| 452 | SRZN | Surrozen, Inc. | 508.06M | -1.43% | 231,862 | 11.51M |
| 453 | NRC | NRC Health | 505.71M | 1.45% | 86,222 | 143.79M |
| 454 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 455 | ANGO | AngioDynamics, Inc. | 504.23M | -2.91% | 475,828 | 325.38M |
| 456 | SENS | Senseonics Holdings, Inc. | 502.83M | -2.46% | 988,584 | 48.55M |
| 457 | DMAC | DiaMedica Therapeutics Inc. | 498.81M | -2.84% | 174,648 | - |
| 458 | OVID | Ovid Therapeutics Inc. | 496.06M | -0.78% | 3,145,558 | 1.58M |
| 459 | AQST | Aquestive Therapeutics, Inc. | 488.24M | -3.71% | 2,419,988 | 54.09M |
| 460 | DCTH | Delcath Systems, Inc. | 487.17M | -4.10% | 427,352 | 95.42M |
| 461 | EVH | Evolent Health, Inc. | 486.16M | 1.18% | 1,145,978 | 2.10B |
| 462 | EOLS | Evolus, Inc. | 485.47M | -2.26% | 794,425 | 316.49M |
| 463 | RCEL | AVITA Medical, Inc. | 484.01M | -6.34% | 597,055 | 75.63M |
| 464 | GYRE | Gyre Therapeutics, Inc. | 482.98M | -28.94% | 394,082 | 109.82M |
| 465 | FTH | Faeth Therapeutics, Inc. | 482.96M | -0.32% | 510,970 | - |
| 466 | BWAY | BrainsWay Ltd. | 478.05M | -4.78% | 123,872 | 60.70M |
| 467 | RGNX | REGENXBIO Inc. | 475.29M | -2.83% | 1,061,621 | 174.48M |
| 468 | INDP | Indaptus Therapeutics, Inc. | 474.57M | -7.49% | 241,849 | - |
| 469 | MNPR | Monopar Therapeutics Inc. | 472.00M | -2.21% | 197,763 | - |
| 470 | SSII | SS Innovations International, Inc. | 470.91M | -1.26% | 49,669 | 52.40M |
| 471 | MASS | 908 Devices Inc. | 465.00M | -12.45% | 551,088 | 60.84M |
| 472 | CERS | Cerus Corporation | 459.48M | -6.56% | 1,503,450 | 221.55M |
| 473 | PHAT | Phathom Pharmaceuticals, Inc. | 455.93M | -7.72% | 1,620,581 | 274.88M |
| 474 | TKNO | Alpha Teknova, Inc. | 454.13M | -9.02% | 651,141 | 43.70M |
| 475 | EPRX | Eupraxia Pharmaceuticals Inc. | 449.68M | -5.79% | 1,222,988 | - |
| 476 | KMDA | Kamada Ltd. | 447.24M | -3.14% | 47,508 | 191.85M |
| 477 | CRMD | CorMedix Inc. | 443.89M | -25.46% | 7,017,384 | 462.25M |
| 478 | BLSM | BlossomHill Therapeutics, Inc. | 437.04M | -9.60% | 156,297 | - |
| 479 | PRTA | Prothena Corporation plc | 434.82M | -4.62% | 452,299 | 54.53M |
| 480 | ASPE | Aspen Neuroscience, Inc. | 432.98M | -0.73% | 1,322,735 | - |
| 481 | NPCE | NeuroPace, Inc. | 422.19M | -5.46% | 80,903 | 106.99M |
| 482 | MPLT | MapLight Therapeutics, Inc. | 421.26M | -1.81% | 394,984 | - |
| 483 | YDES | YD Bio Limited | 420.74M | 1.19% | 47,348 | 1.24M |
| 484 | CCCC | C4 Therapeutics, Inc. | 414.59M | 2.12% | 2,354,094 | 35.04M |
| 485 | RZLT | Rezolute, Inc. | 414.34M | -4.13% | 779,253 | - |
| 486 | EDIT | Editas Medicine, Inc. | 410.06M | -8.87% | 2,909,228 | 47.01M |
| 487 | ASMB | Assembly Biosciences, Inc. | 409.86M | -3.50% | 136,871 | 74.85M |
| 488 | CARL | Carlsmed, Inc. | 408.18M | -5.20% | 73,279 | 63.30M |
| 489 | ALLO | Allogene Therapeutics, Inc. | 407.68M | -5.60% | 9,759,507 | 4.64M |
| 490 | CTEV | Claritev Corporation | 406.74M | - | 199,042 | 994.67M |
| 491 | AUTL | Autolus Therapeutics plc | 404.57M | -3.80% | 1,675,291 | 117.39M |
| 492 | PRLD | Prelude Therapeutics Incorporated | 399.62M | -5.37% | 218,104 | 22.42M |
| 493 | SI | Shoulder Innovations, Inc. | 398.27M | -6.41% | 119,325 | 60.06M |
| 494 | ALT | Altimmune, Inc. | 396.82M | -4.67% | 3,519,865 | 31.00K |
| 495 | SRTA | Strata Critical Medical, Inc. | 392.79M | -6.53% | 1,109,424 | 255.98M |
| 496 | PROK | ProKidney Corp. | 391.51M | -11.90% | 1,730,742 | 818.00K |
| 497 | ZURA | Zura Bio Limited | 389.15M | 4.94% | 4,078,514 | - |
| 498 | TECX | Tectonic Therapeutic, Inc. | 386.69M | -3.51% | 146,258 | - |
| 499 | AVTX | Avalo Therapeutics, Inc. | 384.53M | -3.63% | 1,534,540 | 59.00K |
| 500 | RLMD | Relmada Therapeutics, Inc. | 381.88M | 4.07% | 1,413,755 | - |